Cost evaluation of a nurse coordinated outpatient parenteral antimicrobial therapy (OPAT) program.
| Autor: | Deng H; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA., Gross AE; Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA., Trotter AB; Division of Infectious Disease, Department of Medicine, University of Illinois Chicago College of Medicine, Chicago, IL, USA., Touchette DR; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2024 Jan 03; Vol. 3 (1), pp. e252. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2024). |
| DOI: | 10.1017/ash.2023.526 |
| Abstrakt: | A structured, nurse-driven outpatient parenteral antimicrobial therapy (OPAT) program within an academic healthcare system was associated with reduced odds of 60-day unplanned OPAT readmissions and costs after hospital discharge. These findings may facilitate justifying additional resources for OPAT programs to improve care while decreasing costs. Competing Interests: HD was a research fellow with AbbVie Inc during the year 2020–2022. AG has received honoraria as a consultant for Becton, Dickinson and Company. DRT is the Senior Scientific Advisor for Monument Analytics, a consultant for Astra Zeneca, and has received research funding provided to the University of Illinois Chicago (UIC) from the Institute for Clinical and Economic Review (ICER), AbbVie Inc, and Takeda awarded to the University of Illinois at Chicago. Dr. Touchette also receives royalties for economic models developed for and licensed to ICER through UIC. (© The Author(s) 2024.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|